Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)Alistair Ring, Lucy S Kilburn, Alex Pearson, et al.
Nature Communications|April 24, 2021
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Breast (Edinburgh, Scotland)|October 3, 2018
The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective reviewE Copson, A M Shaaban, T Maishman, et al.
The Lancet. Oncology|September 13, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C Turner, Belinda Kingston, Lucy S Kilburn, et al.
Circulation|September 25, 2023
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE TrialPeter A Henriksen, Peter Hall, Iain R MacPherson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
Cancer Discovery|September 22, 2020
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in <i>PIK3CA</i>-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Joline S J Lim, Iain R Macpherson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2022
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrantLuca Malorni, Svitlana Tyekucheva, Florentine S Hilbers, et al.
Nature Communications|February 16, 2017
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activityJuan R Hernandez-Fernaud, Elena Ruengeler, Andrea Casazza, et al.
EMBO Reports|July 23, 2025
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapesDeclan Whyte, Sophie L Fisher, Christopher G J McKenzie, et al.
Pageof 15